Trial intelligence / Profile preview

Norepinephrine versus phenylephrine for post-spinal hypotension in cesarean delivery and effects on infant gut microbiota

ChiCTR2100044863Phase 4Recruiting

Sponsor
Zigong Fourth People's Hospital
Start
Apr 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of norepinephrine and phenylephrine in maternal hypotension (3 arms), sponsored by Zigong Fourth People's Hospital. Primary endpoints: Composition of infant fecal flora on postoperative day 1 and Composition of infant fecal flora on postoperative day 7. Started Apr 2021; status: recruiting.

02

Drugs

norepinephrinephenylephrine
03

Conditions

maternal hypotension

Beyond the preview

Go deeper on ChiCTR2100044863.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2100044863.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call